The medicine hit its primary endpoint of a decrease in the average daily leg pain intensity as measured by the Numeric Pain ...
icc world cup live A new potential anti-cancer target - PRL2 Trikafta, a triple combination therapy for CF in patients with specific gene mutations, reaches endpoint in Phase III clinical trial Nature ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback